Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization

NCT03486262 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT03486262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03486262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2018
Completion date
February 29, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer and idiopathic pulmonary fibrosis